Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: Preparation and in vitro evaluation in human lung adenocarcinoma cells

Colloids and Surfaces B: Biointerfaces

Volumn 107, Issue , 2013, Pages 115-123

  Yordanov, Georgi ^a   Evangelatov, Alexander ^a   Skrobanska, Ralica ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

A549; Cytotoxicity; Drug uptake; Epirubicin; Lung cancer; Nanoparticles; Poly(butyl cyanoacrylate)

Indexed keywords

A549; DRUG UPTAKE; EPIRUBICIN; LUNG CANCER; POLY(BUTYL CYANOACRYLATE);

ADHESIVES; BIOLOGICAL ORGANS; CYTOTOXICITY; EMULSIONS; MOLECULAR BIOLOGY; RESPIRATORY SYSTEM;

NANOPARTICLES;

EPIRUBICIN; NANOPARTICLE; POLOXAMER; POLY(BUTYL CYANOACRYLATE); POLYMER; POLYSORBATE 80; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG COATING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ZETA POTENTIAL;

ADENOCARCINOMA; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; DRUG SCREENING ASSAYS, ANTITUMOR; ENBUCRILATE; ENDOCYTOSIS; EPIRUBICIN; HUMANS; LIGHT; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; POLYMERIZATION; SCATTERING, RADIATION; STATIC ELECTRICITY;

EID: 84874697242     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.02.002     Document Type: Article

References (80)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. CA Cancer J. Clin. 2005, 55:74.
2. Travis W.D., Travis L.B., Devesa S.S. Cancer 1995, 75:191.
3. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. J. Thorac. Oncol. 2011, 6:244.
4. Stenbygaard L.E., Sørensen J.B., Olsen J.E. J. Thorac. Cardiovasc. Surg. 1995, 110:1130.
5. Shepherd F.A. Semin. Oncol. 1999, 1:3.
6. Einhorn L.H. J. Clin. Oncol. 2008, 26:3485.
7. Bunn P.A., Kelly K. Clin. Cancer Res. 1998, 5:1087.
8. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Pharmacol. Rev. 2004, 56:185.
9. Plosker G.L., Faulds D. Drugs 1993, 45:788.
10. Joss R.A., Hansen H.H., Hansen M., Renard J., Rozencweig M. Eur. J. Cancer Clin. Oncol. 1984, 20:495.
11. Kalman L.A., Kris M.G., Gralla R.J., Kelsen D.P. Cancer Treat. Rep. 1983, 67:591.
12. Feld R., Wierzbicki R., Walde P.L.D., Sheperd F.A., Evans W.K., Gupta S.S., et al. J. Clin. Oncol. 1992, 10:297.
13. Ceresoli G.L., Dell'Oro S., Passoni P., Villa E. Cancer 2000, 89:89.
14. Hsu C., Kuo S.-H., Hu F.-C., Cheng A.-L., Shih J.-Y., Yu C.-J., et al. Lung Cancer 2008, 62:334.
15. Fujii S. Jpn. J. Cancer Chemother. 1992, 19:2103.
16. Kreuter J. Int. J. Pharm. 2007, 331:1.
17. Faraji A., Wipf P. Bioorganic & Medicinal Chemistry 2009, 17:2950.
18. Ruenraroengsak P., Cook J., Florence A. J. Control. Release 2010, 141:265.
19. Maeda H., Sawa T., Konno T. J. Control. Release 2001, 74:47.
20. Torchilin V. Adv. Drug Deliv. Rev. 2011, 63:131.
21. Maeda H. J. Control. Release 2012, 164:138.
22. Matsumura Y., Maeda H. Cancer Res. 1986, 46:6387.
23. Greish K., Sawa T., Fang J., Akaike T., Maeda H. J. Control. Release 2004, 97:219.
24. Greish K., Nagamitsu A., Fang J., Maeda H. Bioconjugate Chem. 2005, 16:230.
25. Azarmi S., Tao X., Chen H., Wang Z., Finlay W.H., Löbenberg R., Roa W.H. Int. J. Pharm. 2006, 319:155.
26. Dziubla T., Muzykantov V. Nanoparticulates as Drug Carriers 2006, Imperial College Press, London, (Chapter 23). V. Torchilin (Ed.).
27. Sung J.C., Pulliam B.L., Edwards D.A. Trends Biotechnol. 2007, 25:563.
28. Azarmi S., Roa W.H., Löbenberg R. Adv. Drug Deliv. Rev. 2008, 60:863.
29. Hawley A., Davis S., Illum L. Adv. Drug Deliv. Rev. 1995, 17:129.
30. Moghimi S., Bonnemain B. Adv. Drug Deliv. Rev. 1999, 37:295.
31. Nishioka Y., Yoshino H. Adv. Drug Deliv. Rev. 2001, 47:55.
32. Oussoren C., Storm G. Adv. Drug Deliv. Rev. 2001, 50:143.
33. Kreuter J. Adv. Drug Deliv. Rev. 2001, 47:65.
34. Ramge P., Unger R., Oltrogge J., Zenker D., Begley D., Kreuter J., Briesen H. Eur. J. Neurosci. 2000, 12:1931.
35. Gulyaev A., Gelperina S., Skidan I., Antropov A., Kivman G., Kreuter J. Pharm. Res. 1999, 16:1564.
36. Wohlfart S., Khalansky A., Bernreuther C., Michaelis M., Cinatl J., Glatzel M., Kreuter J. Int. J. Pharm. 2011, 415:244.
37. Zhou Q., Sun X., Zeng L., Liu J., Zhang Z. Nanomedicine: NBM 2009, 5:419.
38. Salerno M., Cenni E., Fotia C., Avnet S., Granchi D., Castelli F., et al. Curr. Cancer Drug Targets 2010, 10:649.
39. Elazar V., Adwan H., Bäuerle T., Rohekar K., Golomb G., Berger M. Int. J. Cancer 2010, 126:1749.
40. Nicolas J., Couvreur P. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1:111.
41. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., Couvreur P. Adv. Drug Deliv. Rev. 2003, 55:519.
42. Yordanov G. Bulg. J. Chem. 2012, 1:61.
43. Yordanov G., Skrobanska R., Evangelatov A. Colloids Surf. B 2012, 92:98.
44. Yordanov G., Skrobanska R., Evangelatov A. Colloids Surf. B 2013, 101:215.
45. Maksimenko O., Pavlov E., Toushov E., Molin A., Stukalov Y., Prudskova T., Feldman V., Kreuter J., Gelperina S. Int. J. Pharm. 2008, 356:325.
46. Behan N., Birkinshaw C., Clarke N. Biomaterials 2001, 22:1335.
47. Blagoeva P., Balansky R., Mircheva T., Simeonova M. Mutat. Res. 1992, 268:77.
48. Pereverzeva E., Treschalin I., Bodyagin D., Maksimenko O., Kreuter J., Gelperina S. Toxicol. Lett. 2008, 178:9.
49. A. Ambruosi, PhD Thesis, The Johann Wolfgang Goethe University, Germany, 2005.
50. Ambruosi A., Khalansky A., Yamamoto H., Gelperina S., Begley D., Kreuter J. J. Drug Target. 2006, 14:97.
51. Hashizume H., Baluk P., Morikawa S., McLean J., Thurston G., Roberge S., Jain R., McDonald D. Am. J. Pathol. 2000, 156:1363.
52. Reddy L., Sharma R., Chuttani K., Mishra A., Murthy R. J. Control. Release 2005, 105:185.
53. Poupaerta J., Couvreur P. J. Control. Release 2003, 92:19.
54. Ivanova G., Simeonova M., Cabrita E., Rangel M. J. Phys. Chem. B 2011, 115:902.
55. Arias J., Gallardo V., Gomez-Lopera S., Plaza R., Delgado A. J. Control. Release 2001, 77:309.
56. Aggarwal P., Hall J., McLeland C., Dobrovolskaia M., McNeil S. Adv. Drug Deliv. Rev. 2009, 61:428.
57. Gessner A., Lieske A., Paulke B.R., Muller R.H. J. Biomed. Mater. Res. A 2003, 65:319.
58. Kratz F. J. Control. Release 2008, 132:171.
59. De Juan B., Von Briesen H., Gelperina S., Kreuter J. J. Drug Target. 2006, 14:614.
60. Gewirtz D. Biochem. Pharmacol. 1999, 57:727.
61. Hodes M., Palmer C., Warren A. Exp. Cell Res. 1960, 21:164.
62. Li-Blatter X., Nervi P., Seelig A. Biochim. Biophys. Acta Biomembr. 2009, 1788:2335.
63. Sahay G., Alakhova D., Kabanov A. J. Control. Release 2010, 145:182.
64. Zaki N., Tirelli N. Expert Opin. Drug Deliv. 2010, 7:895.
65. Iversen T.-G., Skotland T., Sandvig K. Nano Today 2011, 6:176.
66. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Hirashima N., Kawashima Y. Int. J. Pharm. 2009, 382:198.
67. Yuan H., Miao J., Du Y.-Z., You J., Hu F.-Q., Zeng S. Int. J. Pharm. 2008, 348:137.
68. Harush-Frenkel O., Debotton N., Benita S., Altschuler Y. Biochem. Biophys. Res. Commun. 2007, 353:26.
69. Harush-Frenkel O., Rozentur E., Benita S., Altschuler Y. Biomacromolecules 2008, 9:435.
70. Huang M., Ma Z., Khor E., Lim L.-Y. Pharm. Res. 2002, 19:1488.
71. Chiannilkulchai N., Ammoury N., Caillou B., Devissaguet J., Couvreur P. Cancer Chemother. Pharmacol. 1990, 26:122.
72. Al-Hallak K., Azarmi S., Anwar-Mohamed A., Roa W., Löbenberg R. Eur. J. Pharm. Biopharm. 2010, 76:112.
73. Ruge C., Kirch J., Cañadas O., Schneider M., Perez-Gil J., Schaefer U., Casals C., Lehr C. Nanomedicine 2011, 7:690.
74. Bennis S., Chapey C., Couvreur P., Robert J. Eur. J. Cancer 1994, 30A:89.
75. Couvreur P., Kante B., Grislain L., Roland M., Speiser P. J. Pharm. Sci. 1982, 71:790.
76. Gibaud S., Andreux J., Weingarten C., Renard M., Couvreur P. Eur. J. Cancer 1994, 30:820.
77. Fernandez-Urrusuno R., Fattal E., Porquet D., Feger J., Couvreur P. Toxicol. Appl. Pharmacol. 1995, 130:272.
78. Simeonova M., Antcheva M., Chorbadjiev K. Biomaterials 2003, 24:313.
79. Szebeni J. Toxicology 2005, 216:106.
80. Kattan J., Droz P., Couvreur P., Marino P., Boutan-Laroze A., Rougier P., Brault P., Vranckx H., Grognet J.M., Morge X., Sancho-Garnier H. Invest. New Drugs 1992, 10:191.